Search and Browse
Download
Enter Data
| Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215446 (US9296745, 1) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet  | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.70 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Pfizer Inc. US Patent | Assay Description For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of c... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215552 (US9296745, 109-A | US9296745, 109-B | US9296745, 1...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase MCE PC cid PC sid UniChem | US Patent | n/a | n/a | 2.10 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description For evaluation of the effects of DGAT2 inhibitors in a cell-based setting, cryopreserved human hepatocytes (Lot QOC, Celsis, Chicago, Ill.) were thaw... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215661 (US9296745, 199) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description For evaluation of the effects of DGAT2 inhibitors in a cell-based setting, cryopreserved human hepatocytes (Lot QOC, Celsis, Chicago, Ill.) were thaw... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215447 (US9296745, 2) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.71 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Pfizer Inc. US Patent | Assay Description For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of c... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215551 (US9296745, 108) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.80 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description For evaluation of the effects of DGAT2 inhibitors in a cell-based setting, cryopreserved human hepatocytes (Lot QOC, Celsis, Chicago, Ill.) were thaw... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215487 (US9296745, 42) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.18 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Pfizer Inc. US Patent | Assay Description For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of c... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215599 (US9296745, 158) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.58 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Pfizer Inc. US Patent | Assay Description For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of c... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215486 (US9296745, 154 | US9296745, 41) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.56 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Pfizer Inc. US Patent | Assay Description For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of c... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215629 (US9296745, 196-A | US9296745, 196-B) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.60 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description For evaluation of the effects of DGAT2 inhibitors in a cell-based setting, cryopreserved human hepatocytes (Lot QOC, Celsis, Chicago, Ill.) were thaw... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215448 (US9296745, 3) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.82 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Pfizer Inc. US Patent | Assay Description For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of c... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215568 (US9296745, 124) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.27 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Pfizer Inc. US Patent | Assay Description For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of c... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215660 (US9296745, 197) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description For evaluation of the effects of DGAT2 inhibitors in a cell-based setting, cryopreserved human hepatocytes (Lot QOC, Celsis, Chicago, Ill.) were thaw... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215552 (US9296745, 109-A | US9296745, 109-B | US9296745, 1...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase MCE PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description For evaluation of the effects of DGAT2 inhibitors in a cell-based setting, cryopreserved human hepatocytes (Lot QOC, Celsis, Chicago, Ill.) were thaw... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215549 (US9296745, 106) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.68 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Pfizer Inc. US Patent | Assay Description For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of c... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215594 (US9296745, 153 | US9296745, 182) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.03 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Pfizer Inc. US Patent | Assay Description For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of c... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215579 (US9296745, 136) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.32 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Pfizer Inc. US Patent | Assay Description For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of c... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215485 (US9296745, 40) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.47 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Pfizer Inc. US Patent | Assay Description For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of c... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215449 (US9296745, 4) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.64 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Pfizer Inc. US Patent | Assay Description For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of c... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215484 (US9296745, 39) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.85 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Pfizer Inc. US Patent | Assay Description For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of c... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215572 (US9296745, 128) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.16 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Pfizer Inc. US Patent | Assay Description For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of c... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215488 (US9296745, 155 | US9296745, 43) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.41 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Pfizer Inc. US Patent | Assay Description For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of c... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215631 (US9296745, 198) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.80 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description For evaluation of the effects of DGAT2 inhibitors in a cell-based setting, cryopreserved human hepatocytes (Lot QOC, Celsis, Chicago, Ill.) were thaw... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215483 (US9296745, 38) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.81 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Pfizer Inc. US Patent | Assay Description For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of c... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215517 (US9296745, 73) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.90 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description For evaluation of the effects of DGAT2 inhibitors in a cell-based setting, cryopreserved human hepatocytes (Lot QOC, Celsis, Chicago, Ill.) were thaw... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215450 (US9296745, 5) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 8.24 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Pfizer Inc. US Patent | Assay Description For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of c... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215640 (US9296745, 209) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 8.90 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description For evaluation of the effects of DGAT2 inhibitors in a cell-based setting, cryopreserved human hepatocytes (Lot QOC, Celsis, Chicago, Ill.) were thaw... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215589 (US9296745, 147) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 9.21 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Pfizer Inc. US Patent | Assay Description For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of c... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215556 (US9296745, 112) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 9.23 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Pfizer Inc. US Patent | Assay Description For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of c... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215522 (US9296745, 78) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 9.40 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description For evaluation of the effects of DGAT2 inhibitors in a cell-based setting, cryopreserved human hepatocytes (Lot QOC, Celsis, Chicago, Ill.) were thaw... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215528 (US9296745, 84) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 9.55 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Pfizer Inc. US Patent | Assay Description For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of c... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215623 (US9296745, 187) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 10.5 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Pfizer Inc. US Patent | Assay Description For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of c... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215492 (US9296745, 48) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 10.7 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Pfizer Inc. US Patent | Assay Description For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of c... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215584 (US9296745, 141) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 10.7 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description For evaluation of the effects of DGAT2 inhibitors in a cell-based setting, cryopreserved human hepatocytes (Lot QOC, Celsis, Chicago, Ill.) were thaw... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215566 (US9296745, 122) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 10.9 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Pfizer Inc. US Patent | Assay Description For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of c... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215451 (US9296745, 6) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 11.5 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Pfizer Inc. US Patent | Assay Description For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of c... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215482 (US9296745, 37) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 12.6 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Pfizer Inc. US Patent | Assay Description For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of c... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215552 (US9296745, 109-A | US9296745, 109-B | US9296745, 1...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase MCE PC cid PC sid UniChem | US Patent | n/a | n/a | 13.8 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Pfizer Inc. US Patent | Assay Description For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of c... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215565 (US9296745, 121) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 14.3 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Pfizer Inc. US Patent | Assay Description For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of c... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215629 (US9296745, 196-A | US9296745, 196-B) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 14.5 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Pfizer Inc. US Patent | Assay Description For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of c... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215620 (US9296745, 184) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 15.2 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Pfizer Inc. US Patent | Assay Description For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of c... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215526 (US9296745, 82) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 15.8 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description For evaluation of the effects of DGAT2 inhibitors in a cell-based setting, cryopreserved human hepatocytes (Lot QOC, Celsis, Chicago, Ill.) were thaw... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215538 (US9296745, 95) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 15.9 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description For evaluation of the effects of DGAT2 inhibitors in a cell-based setting, cryopreserved human hepatocytes (Lot QOC, Celsis, Chicago, Ill.) were thaw... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215452 (US9296745, 7) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 16.3 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Pfizer Inc. US Patent | Assay Description For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of c... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215538 (US9296745, 95) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 18.2 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Pfizer Inc. US Patent | Assay Description For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of c... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215643 (US9296745, 212) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 18.9 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Pfizer Inc. US Patent | Assay Description For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of c... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215661 (US9296745, 199) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 18.9 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Pfizer Inc. US Patent | Assay Description For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of c... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215552 (US9296745, 109-A | US9296745, 109-B | US9296745, 1...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase MCE PC cid PC sid UniChem | US Patent | n/a | n/a | 20.2 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Pfizer Inc. US Patent | Assay Description For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of c... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215481 (US9296745, 36) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 20.7 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Pfizer Inc. US Patent | Assay Description For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of c... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215453 (US9296745, 8) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 21.1 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Pfizer Inc. US Patent | Assay Description For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of c... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM215480 (US9296745, 35) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 21.2 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Pfizer Inc. US Patent | Assay Description For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of c... | US Patent US9296745 (2016) BindingDB Entry DOI: 10.7270/Q25719VW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Displayed 1 to 50 (of 236 total ) | Next | Last >> |
